Bio-IT World News Brief | A team led by researchers from The University of Texas MD Anderson Cancer Center reports that a key difference between the few pancreatic cancer patients who survive long-term and the many whose disease overcomes all treatments is the bacterial signatures on their tumors that either stimulate or suppress immune response.

Bio-IT World Contributed Commentary | The United States Patent and Trademark Office released new guidance earlier this year that appears to have somewhat reversed the trend of increased patentable subject matter ineligibility for bioinformatics patent applications.